Skip to main content
Clinical Trials/NCT03990792
NCT03990792
Completed
Not Applicable

Preventing the Onset of Depression Through a Personalized Intervention Based on ICTs, Risk Prediction Algorithms and Decision Support Systems for Patients and GPs: the e-predictD Study

The Mediterranean Institute for the Advance of Biotechnology and Health Research6 sites in 1 country663 target enrollmentFebruary 1, 2020
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Enrollment
663
Locations
6
Primary Endpoint
Incidence of major depression measured by the Composite International Diagnostic Interview (CIDI)
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

The main goal is to design, develop and evaluate a personalized intervention to prevent the onset of depression based on Information and Communications Technology (ICTs), risk predictive algorithms and decision support systems (DSS) for patients and general practitioners (GPs). The specific goals are 1) to design and develop a DSS, called e-predictD-DSS, to elaborate personalized plans to prevent depression; 2) to design and develop an ICT solution that integrates the DSS on the web, a mobile application (App), the risk predictive algorithm, different intervention modules and a monitoring-feedback system; 3) to evaluate the usability and adherence of primary care patients and their GPs with the e-predictD intervention; 4) to evaluate the effectiveness of the e-predictD intervention to reduce the incidence of major depression, depression and anxiety symptoms and the probability of major depression next year; 5) to evaluate the cost-effectiveness and cost-utility of the e-predictD intervention to prevent depression.

Methods: This is a randomized controlled trial with allocation by cluster (GPs), simple blind, two parallel arms (e-predictD vs "active m-Health control") and 1 year follow-up including 720 patients (360 in each arm) and 72 GPs (36 in each arm). Patients will be free of major depression at baseline and aged between 18 and 55 years old. Primary outcome will be the incidence of major depression at 12 months measured by CIDI. As secondary outcomes: depressive and anxiety symptomatology measured by PHQ-9 and GAD-7 and the risk probability of depression measured by predictD algorithm, as well as cost-effectiveness and cost-utility. The e-predictD intervention is multi-component and it is based on a DSS that helps the patients to elaborate their own personalized depression prevention plans, which the patient approves, and implements, and the system monitors offering feedback to the patient and to the GPs. It is an e-Health intervention because it is based on a web and m-Health because it is also implemented on the patient's smartphones through an App. In addition, it integrates a risk algorithm of depression, which is already validated (the predictD algorithm). It also includes an initial GP-patient interview and a specific training for the GP. Finally, a map of potentially useful local community resources to prevent depression will be integrated into the DSS.

Registry
clinicaltrials.gov
Start Date
February 1, 2020
End Date
December 31, 2023
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Responsible Party
Principal Investigator
Principal Investigator

Juan Ángel Bellón

PhD, Medicine

Andalusian Health Service

Eligibility Criteria

Inclusion Criteria

  • PHQ-9 \<10 at baseline
  • Moderate-high risk of depression (predictD risk algorithm score ≥ 10%)

Exclusion Criteria

  • Not have a smartphone and internet for personal use
  • Unable to speak Spanish
  • Documented terminal illness
  • Documented cognitive impairment
  • Limiting sensory disorder (e.g. deafness)
  • Documented serious mental illness (psychosis, bipolar, addictions, etc.)

Outcomes

Primary Outcomes

Incidence of major depression measured by the Composite International Diagnostic Interview (CIDI)

Time Frame: 12 months

Composite International Diagnostic Interview (CIDI) is a structured diagnostic interview that provides current diagnoses of major depression

Secondary Outcomes

  • Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9)(12 months)
  • Anxious symptoms measured by the General Anxiety Questionnaire (GAD-7)(12 months)
  • Probability of depression (predictD risk algorithm)(12 months)
  • Cost-effectiveness and cost-utility(12 months)

Study Sites (6)

Loading locations...

Similar Trials